A 58-year-old man with acute coronary syndrome is on dual antiplatelet therapy (aspirin + clopidogrel). Which feature best distinguishes clopidogrel from aspirin in terms of mechanism of action and clinical implications?

## Distinguishing Clopidogrel from Aspirin ### Mechanism and Activation **Key Point:** The most clinically relevant discriminator between clopidogrel and aspirin is that clopidogrel is a **prodrug** requiring hepatic CYP450 metabolism (primarily CYP3A4 and CYP2C19) to generate its active thiol metabolite, whereas aspirin is directly active. ### Comparison Table | Feature | Aspirin | Clopidogrel | | --- | --- | --- | | **Drug class** | Salicylate (NSAID) | Thienopyridine (P2Y12 inhibitor) | | **Activation** | Direct (no metabolism needed) | Prodrug (requires CYP450) | | **Target** | COX-1 → ↓ TXA2 | P2Y12 ADP receptor | | **Reversibility** | Irreversible (covalent) | Irreversible (covalent) | | **Onset** | 15–30 min | 2–4 hours (loading dose) | | **Platelet effect duration** | 7–10 days | 7–10 days | | **CYP450 interactions** | None | High (CYP2C19 inhibitors reduce efficacy) | ### Clinical Significance of Prodrug Status **High-Yield:** Clopidogrel's prodrug nature has major exam-tested implications: 1. **Drug interactions:** CYP2C19 inhibitors (omeprazole, esomeprazole, cimetidine) reduce clopidogrel activation → reduced antiplatelet effect → increased stent thrombosis risk. This is a classic NEET PG trap. 2. **Genetic polymorphisms:** CYP2C19 loss-of-function variants (poor metabolizers) reduce clopidogrel efficacy, necessitating prasugrel or ticagrelor as alternatives. 3. **Loading dose requirement:** Because clopidogrel is a prodrug, a 300–600 mg loading dose is needed to achieve rapid platelet inhibition; aspirin works immediately. **Clinical Pearl:** A patient on clopidogrel who is also prescribed omeprazole for GI protection is at risk of reduced clopidogrel efficacy and stent thrombosis — a common exam scenario. Switching to pantoprazole (weaker CYP2C19 inhibitor) or H2 blockers mitigates this risk. **Mnemonic:** **PROD** — Prodrug Requiring Oxidative Degradation (clopidogrel) vs Direct action (aspirin). ### Why Other Options Are Incorrect - **Option 0 (Irreversible inhibition lasting platelet lifespan):** Both aspirin AND clopidogrel are irreversible inhibitors with effects lasting 7–10 days (the lifespan of platelets). This is NOT a discriminator. - **Option 2 (Direct inhibition of TXA2):** This is aspirin's mechanism, not clopidogrel's. Clopidogrel inhibits ADP-mediated platelet activation via P2Y12 receptor blockade, not TXA2 synthesis. - **Option 3 (Rapid onset within 15–30 min):** Aspirin has rapid onset (15–30 min); clopidogrel requires 2–4 hours even with a loading dose due to the time needed for hepatic activation. This is the opposite of the correct answer.